Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During Ramadan

Summary

This study will assess if Sitagliptin addition to metformin or glitazone is better than current sulphonylurea based treatments during Ramadan. The rationale is that Sitagliptin offers metabolic advantages primarily with the low incidence of hypoglycemia over current sulphonylurea based treatments.

Timeline

Start

2008-08

Primary completion

2009-10

Completion

2009-10

Drugs

Indications